ArticleBiochimica et biophysica acta. Molecular basis of disease2022

The nuclear receptor TLX (NR2E1) inhibits growth and progression of triple- negative breast cancer.

Adam T Nelczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.